Vascular Complications with Newer Generations of Angioseal Vascular Closure Devices
- 15 February 2006
- journal article
- clinical trial
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 19 (1) , 67-74
Abstract
Objectives: To evaluate the safety and efficacy of newer generations of a single vascular closure device (VCD), Angioseal, compared to contemporaneous manual compression. Background: Previous assessment of VCD safety and efficacy has been based primarily on outcomes associated with the original VCD. Few data exist comparing safety and efficacy of modifications of the original VCDs. Methods: We evaluated in‐hospital outcomes of patients undergoing diagnostic cath and percutaneous coronary intervention at a single center: 3,898 with manual compression and 3,898 with the Angioseal VCD. Three generations of the Angioseal device were studied: Generation 1, 7/97–4/00; Generation 2, 5/00–6/02; and Generation 3, 7/02–12/03. Propensity analysis was used to match patients within each generation for clinical and procedural covariates. Results: Closure success was 98.5% for Generation 1, 98.6% for Generation 2, and 98.1% for Generation 3, P = NS. The odds ratio for any vascular complication comparing Angioseal to manual compression was 0.92 (0.42–2.01) for Generation 1; 0.83 (0.49–1.41) for Generation 2; and 0.75 (0.32–1.77) for Generation 3. Multivariate logistic regression identified closure success and Angioseal device Generation 3 versus Generation 1 as predictive of reduced vascular complications during the entire study period. Conclusion: These data indicate that the newest generation of the Angioseal VCD is at least as effective as the original device. Moreover, use of the Angioseal VCD was associated with vascular complications similar to or lower than vascular complications following manual compression for each generation of Angioseal device analyzed.Keywords
This publication has 12 references indexed in Scilit:
- Arterial Puncture Closing Devices Compared With Standard Manual Compression After Cardiac CatheterizationJAMA, 2004
- Vascular closure devices in patients treated with anticoagulation and iib/iiia receptor inhibitors during percutaneous revascularizationJACC, 2002
- Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trialAmerican Heart Journal, 2001
- Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitorsThe American Journal of Cardiology, 2001
- Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devicesJACC, 2001
- Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND ii) trialsThe American Journal of Cardiology, 2000
- A single center randomized trial assessing use of a vascular hemostasis device vs. conventional manual compression following ptca: What are the potential resource savings?Catheterization and Cardiovascular Diagnosis, 1995
- Immediate arterial hemostasis after cardiac catheterization: Initial experience with a new puncture closure deviceCatheterization and Cardiovascular Diagnosis, 1994
- A multicenter randomized trial comparing a percutaneous collagen hemotasis device with conventional manual compression after diagnostic angiography and angioplastyJACC, 1993
- Collagen application for sealing of arterial puncture sites in comparison to pressure dressing: A randomized trialCatheterization and Cardiovascular Diagnosis, 1992